Olfaction Disorders Clinical Trial
Official title:
Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive
One of the most common causes of loss of smell is upper respiratory tract infection. These disorders can be quantitative (hyposmia or anosmia) or qualitative (parosmia or phantosmia). Loss of smell has been found as a major and frequent clinical sign of Sars Cov2 infection (more than 50% of patients screened at the CHU Nancy). Spontaneous recovery remains possible. It usually occurs in the first month . But when symptoms persist, the therapeutic management of post-viral anosmias is poorly codified in the literature. Olfactory rehabilitation could allow faster recovery and better quality, but the published protocols are numerous and could only be tested on small inhomogeneous series of patients (mixture of post-viral and post-traumatic hypo-ansomy). The significant increase in the population of patients suffering from post-viral anosmia following the current pandemic situation makes it possible to consider a prospective study aiming to compare two olfactory rehabilitation protocols: "classic" and "intensive" in a population of patients. suffering only from post-viral hypoanosmia. Hypothesis: Intensive or classic olfactory rehabilitation allows better results than spontaneous recovery
80 patients will be recruited from among the patients consulting the otorhinolaryngology department of the Nancy CHRU for the assessment of viral post-infectious olfactory disorders. The inclusion visit will be carried out during a standard routine care consultation with the following: - an endoscopic endonasal examination - the olfactory assessment (evaluation of smell by self-assessment, Dynachron-olfaction questionnaire, olfactory test by Sniffin 'Stick) At the end of this assessment and after having received the information on the study and signed the consent form, the patients confirmed to be hypo-anosmic will then be randomized into 2 groups: - "classic" olfactory rehabilitation group - "intensive" olfactory rehabilitation group The rehabilitation kits (8 jars or 4 jars depending on the randomization group) will be provided to the patient with therapeutic education in their use. The patient will carry out olfactory rehabilitation (intensive or classic) at home twice a day (morning and evening) for 32 weeks (i.e. 448 sessions). The patient will smell each odor for 10 seconds with an interval of 10 seconds between odors. Each training will be recorded by the patient in his olfactory rehabilitation agenda. The patient will go again for a follow-up consultation for the renewal of his olfactory assessment at 4 months (follow-up visit 1) and at 8 months (follow-up visit 2) post-inclusion as part of the routine care of disorders of the smell post virus infection. In addition to the olfactory assessment during these visits, the investigator will also verify that the rehabilitation schedule is being kept. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04526054 -
Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients
|
N/A | |
Recruiting |
NCT04799977 -
COVID-19: Post-covid Olfactory Disorders Assessment
|
||
Completed |
NCT04529161 -
Olfactory and Taste Changes During Fasting Mimicking Diet (FMD)
|
N/A | |
Completed |
NCT00660868 -
Is Pentoxifylline Able to Improve Olfactory Sensitivity?
|
N/A | |
Completed |
NCT04361474 -
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
|
Phase 3 | |
Withdrawn |
NCT01814618 -
Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery
|
Phase 2 | |
Completed |
NCT03698760 -
Computerized Olfactory Test - Alzheimer Disease Mild Stage
|
N/A | |
Completed |
NCT04406584 -
Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction
|
N/A | |
Completed |
NCT02565121 -
Olfaction Disorders in Patients Included in The Trauma Brain Injury (TBI) Database at Trondheim University Hospital
|
N/A | |
Recruiting |
NCT05364125 -
Olfactory Training on Smell Dysfunction Patients in HK
|
N/A | |
Withdrawn |
NCT04696601 -
Rapid Screening for Olfactory Disorders in Covid-19 Infection
|
N/A | |
Terminated |
NCT04104594 -
Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal Polyps
|
N/A | |
Withdrawn |
NCT03043144 -
Taste And Smell TEsting in End Stage Renal Disease
|
N/A | |
Recruiting |
NCT06204432 -
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
|
Phase 2 | |
Recruiting |
NCT04390646 -
GnRH Therapy on Cognition in Down Syndrome
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT05666492 -
"Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction.
|
N/A |